Bioorganic & Medicinal Chemistry 2009-08-15

Synthesis of [19, 35, 36-(13)C(3)]-labeled TAK779 as a molecular probe.

Hiroyuki Konno, Saburo Aimoto, Steven O Smith, Kazuto Nosaka, Kenichi Akaji

文献索引：Bioorg. Med. Chem. 17(16) , 5769-74, (2009)

全文：HTML全文

摘要

N,N-Dimethyl-N-[4-[[[2-(4-methylphenyl)-6,7-dihydro-5H-benzocyclohepten-8-yl]carbonyl]amino]benzyl]tetrahydro-2H-pyran-4-aminium chloride (TAK779) is a potent and selective non-peptide CCR5 antagonist. To use a site-specifically labeled form as a molecular probe, TAK779 containing (13)C at positions C19, 35, and 36 was produced. A commercially available [(13)C]-methyl iodide was employed for the labeling. Starting from a known carboxylic acid segment containing no labeled carbon, the labeled TAK779 was constructed by the successive coupling of [(13)C]-labeled tolyl boronic ester by the Suzuki-Miyaura reaction and a [(13)C]-labeled aniline segment by amide bond formation.

相关化合物

  • TAK-779

相关文献：

Effects of a calcineurin inhibitor, FK506, and a CCR5/CXCR3 antagonist, TAK-779, in a rat small intestinal transplantation model.

2011-07-01

[Transpl. Immunol. 25(1) , 49-55, (2011)]

Evolution of CCR5 antagonist resistance in an HIV-1 subtype C clinical isolate.

2010-12-01

[J. Acquir. Immune Defic. Syndr. 55(4) , 420-7, (2010)]

HIV-1 clinical isolates resistant to CCR5 antagonists exhibit delayed entry kinetics that are corrected in the presence of drug.

2012-01-01

[J. Virol. 86(2) , 1119-28, (2012)]

C-C chemokine receptor type 5 (CCR5) utilization of transmitted and early founder human immunodeficiency virus type 1 envelopes and sensitivity to small-molecule CCR5 inhibitors.

2010-12-01

[J. Gen. Virol. 91(Pt 12) , 2965-73, (2010)]

Blockade of Th1 chemokine receptors ameliorates pulmonary granulomatosis in mice.

2011-08-01

[Eur. Respir. J. 38(2) , 415-24, (2011)]

更多文献...